Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tegafur/gimeracil/oteracil vs doxifluridine plus oxaliplatin in metastatic gastric cancer
CTR20130950Phase 2Completed
- Sponsor
- Yangtze River Pharmaceutical Group
- Start
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tegafur in gastric cancer (GC), sponsored by Yangtze River Pharmaceutical Group. Started Jun 2014; status: completed.
02
Drugs
tegafur
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on CTR20130950.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20130950.